Sectors
LBRX
LB Pharmaceuticals Inc Common Stock
45.61
1 x 42.14
1 x 46.80
bid
ask
-
0.24
0.52%
09:38 AM
timesize
| Ytd | 104.90% | |
| 1y | 163.65% |
43.61
day range
45.92
13.36
52 week range
49.14
| Open | 45.90 | Prev Close | 45.85 | Low | 43.61 | High | 45.92 | Mkt Cap | 1.31B |
| Vol | 3.21K | Avg Vol | 304.74K | EPS | -1.73 | P/E | -26.36 | Forward P/E | -11.47 |
| Beta | N/A | Short Ratio | 11.99 | Inst. Own | 109.12% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 33.46 | 200-d Avg | 25.68 | 1yr Est | 45.88 |
LBRX News
benzinga.com
HC Wainwright & Co. Reiterates Buy on LB Pharmaceuticals, Maintains $45 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates LB Pharmaceuticals (NASDAQ:LBRX) wi
benzinga.com
LB Pharmaceuticals Commences ~$150M Offering Of Common Shares, Pre-Funded Warrants
LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a neu
benzinga.com
LB Pharma Now Expects To Report Topline Results From Pivotal Phase 3 NOVA-2 Clinical Trial Of LB-102
LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (NASDAQ:LBRX), a neur
benzinga.com
BMO Capital Initiates Coverage On LB Pharmaceuticals with Outperform Rating, Announces Price Target
BMO Capital analyst Malcolm Hoffman initiates coverage on LB Pharmaceuticals (NASDAQ:LBRX) with a
benzinga.com
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday